These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1188 related items for PubMed ID: 17922973

  • 1. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT, Wu X, Fayad F, Fowler JF, Amendola BE, García S, Han H, de la Zerda A, Bossart E, Huang Z, Schwade JG.
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [Abstract] [Full Text] [Related]

  • 2. Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors.
    Brown WT, Wu X, Wen BC, Fowler JF, Fayad F, Amendola BE, García S, De La Zerda A, Huang Z, Schwade JG.
    Comput Aided Surg; 2007 Sep; 12(5):253-61. PubMed ID: 17957532
    [Abstract] [Full Text] [Related]

  • 3. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
    Brown WT, Wu X, Amendola B, Perman M, Han H, Fayad F, Garcia S, Lewin A, Abitbol A, de la Zerda A, Schwade JG.
    Cancer J; 2007 Sep; 13(2):87-94. PubMed ID: 17476136
    [Abstract] [Full Text] [Related]

  • 4. Treatment of stage I non-small cell lung cancer with CyberKnife, image-guided robotic stereotactic radiosurgery.
    Ahn SH, Han MS, Yoon JH, Jeon SY, Kim CH, Yoo HJ, Lee JC.
    Oncol Rep; 2009 Mar; 21(3):693-6. PubMed ID: 19212628
    [Abstract] [Full Text] [Related]

  • 5. Lung metastases treated by CyberKnife image-guided robotic stereotactic radiosurgery at 41 months.
    Brown WT, Wu X, Fowler JF, García S, Fayad F, Amendola BE, de la Zerda A, Schwade JG.
    South Med J; 2008 Apr; 101(4):376-82. PubMed ID: 18360342
    [Abstract] [Full Text] [Related]

  • 6. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent.
    Brown WT, Wu X, Fayad F, Fowler JF, García S, Monterroso MI, de la Zerda A, Schwade JG.
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):623-31. PubMed ID: 19682875
    [Abstract] [Full Text] [Related]

  • 7. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
    van der Voort van Zyp NC, Prévost JB, Hoogeman MS, Praag J, van der Holt B, Levendag PC, van Klaveren RJ, Pattynama P, Nuyttens JJ.
    Radiother Oncol; 2009 Jun; 91(3):296-300. PubMed ID: 19297048
    [Abstract] [Full Text] [Related]

  • 8. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
    Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K.
    Cancer; 2007 Jul 01; 110(1):148-55. PubMed ID: 17516437
    [Abstract] [Full Text] [Related]

  • 9. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
    Zimmermann FB, Geinitz H, Schill S, Thamm R, Nieder C, Schratzenstaller U, Molls M.
    Acta Oncol; 2006 Jul 01; 45(7):796-801. PubMed ID: 16982542
    [Abstract] [Full Text] [Related]

  • 10. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning.
    Coon D, Gokhale AS, Burton SA, Heron DE, Ozhasoglu C, Christie N.
    Clin Lung Cancer; 2008 Jul 01; 9(4):217-21. PubMed ID: 18650169
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure.
    Andratschke N, Zimmermann F, Boehm E, Schill S, Schoenknecht C, Thamm R, Molls M, Nieder C, Geinitz H.
    Radiother Oncol; 2011 Nov 01; 101(2):245-9. PubMed ID: 21724287
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
    Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y, Li P, Chang JY.
    Int J Radiat Oncol Biol Phys; 2006 Sep 01; 66(1):117-25. PubMed ID: 16765528
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):348-53. PubMed ID: 22104360
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.
    Temming S, Kocher M, Stoelben E, Hagmeyer L, Chang DH, Frank K, Hekmat K, Wolf J, Baus WW, Semrau R, Baues C, Marnitz S.
    Strahlenther Onkol; 2018 Feb 01; 194(2):91-97. PubMed ID: 28812120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.